Show simple item record

Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients

dc.contributor.authorOrkin, C
dc.contributor.authorEron, JJ
dc.contributor.authorRockstroh, J
dc.contributor.authorPodzamczer, D
dc.contributor.authorEsser, S
dc.contributor.authorVandekerckhove, L
dc.contributor.authorVan Landuyt, E
dc.contributor.authorLathouwers, E
dc.contributor.authorHufkens, V
dc.contributor.authorJezorwski, J
dc.contributor.authorOpsomer, M
dc.contributor.authorGrp, AMBERS
dc.date.accessioned2020-11-12T16:17:20Z
dc.date.available2020-11-12T16:17:20Z
dc.date.issued2020-04-01
dc.identifier.issn0269-9370
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/68265
dc.format.extent707 - 718
dc.publisherWolters Kluwer Health, Incen_US
dc.relation.ispartofAIDS
dc.rightsDistributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND)
dc.subjectART-naiveen_US
dc.subjectdarunaviren_US
dc.subjectcobicistaten_US
dc.subjectemtricitabineen_US
dc.subjecttenofovir alafenamideen_US
dc.subjectefficacyen_US
dc.subjectsafetyen_US
dc.subjectsingle-tablet regimenen_US
dc.titleWeek 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patientsen_US
dc.typeArticleen_US
dc.rights.holder(c) 2019 The Author(s)
dc.identifier.doi10.1097/QAD.0000000000002463
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524576600007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue5en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume34en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record